- Home
- ASND vs HIMS Comparison
ASND vs HIMS Comparison
Compare ASND & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- HIMS
- Stock Information
- Founded
- ASND 2006
- HIMS 2017
- Country
- ASND Denmark
- HIMS United States
- Employees
- ASND 1017
- HIMS N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- HIMS Medical/Nursing Services
- Sector
- ASND Health Care
- HIMS Health Care
- Exchange
- ASND Nasdaq
- HIMS Nasdaq
- Market Cap
- ASND 12.2B
- HIMS 12.2B
- IPO Year
- ASND 2015
- HIMS N/A
- Fundamental
- Price
- ASND $208.32
- HIMS $42.53
- Analyst Decision
- ASND Strong Buy
- HIMS Hold
- Analyst Count
- ASND 17
- HIMS 12
- Target Price
- ASND $245.76
- HIMS $42.80
- AVG Volume (30 Days)
- ASND 407.0K
- HIMS 30.3M
- Earning Date
- ASND 11-04-2025
- HIMS 11-03-2025
- Dividend Yield
- ASND N/A
- HIMS N/A
- EPS Growth
- ASND N/A
- HIMS 20.34
- EPS
- ASND N/A
- HIMS 0.53
- Revenue
- ASND $576,332,355.00
- HIMS $2,210,958,000.00
- Revenue This Year
- ASND $104.98
- HIMS $61.73
- Revenue Next Year
- ASND $79.91
- HIMS $19.43
- P/E Ratio
- ASND N/A
- HIMS $79.76
- Revenue Growth
- ASND 54.50
- HIMS 78.02
- 52 Week Low
- ASND $118.03
- HIMS $19.15
- 52 Week High
- ASND $216.45
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- ASND 57.09
- HIMS 35.42
- Support Level
- ASND $195.03
- HIMS $44.05
- Resistance Level
- ASND $208.39
- HIMS $47.24
- Average True Range (ATR)
- ASND 8.24
- HIMS 3.21
- MACD
- ASND -0.46
- HIMS -0.95
- Stochastic Oscillator
- ASND 78.36
- HIMS 0.59
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.